(PTI) Shares of Biocon climbed nearly 8 per cent on Wednesday after the biotechnology major's consolidated net profit increased 31 per cent for the March quarter.
The stock gained 7.12 per cent to ₹259.50 on the BSE.
At the NSE, it rallied 7.61 per cent to ₹260.60.
Biocon on Tuesday said its consolidated net profit increased 31 per cent to ₹313 crore for the March quarter on the back of robust sales.
The company had reported a net profit of ₹239 crore in January-March 2021-22.
Total revenue increased to ₹3,929 crore in the fourth quarter as against ₹2,476 crore in the year-ago period, Biocon said in a statement.
For the year ended March 31, 2023, the company reported a consolidated net profit of ₹463 crore as against ₹648 crore in 2021-22.
Total revenue, however, increased to ₹11,550 crore as compared with ₹8,397 crore in FY22.
